FDA Clears Long-Acting ADHD Drug Mydayis FDA Clears Long-Acting ADHD Drug Mydayis

Mydayis (mixed salts of amphetamine) is formulated to last up to 16 hours and is approved for adults and children aged 13 years and older.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news